These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17922049)

  • 1. Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implications.
    Pérez-Gutiérrez S; González-Cámpora R; Amérigo-Navarro J; Beato-Moreno A; Sánchez-León M; Pareja Megía JM; Virizuela-Echaburu JA; López-Beltrán A
    Pathol Oncol Res; 2007; 13(3):203-8. PubMed ID: 17922049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.
    Plaat BE; Hollema H; Molenaar WM; Torn Broers GH; Pijpe J; Mastik MF; Hoekstra HJ; van den Berg E; Scheper RJ; van der Graaf WT
    J Clin Oncol; 2000 Sep; 18(18):3211-20. PubMed ID: 10986053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal stromal tumors and leiomyosarcomas.
    Katz SC; DeMatteo RP
    J Surg Oncol; 2008 Mar; 97(4):350-9. PubMed ID: 18286477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
    Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
    Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
    Liang YM; Li XH; Li WM; Lu YY
    World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large national comparative study of clinicopathological features and long-term survivals between esophageal gastrointestinal stromal tumor and leiomyosarcoma.
    Azab B; Macedo FI; Cass SH; Ripat C; Razi SS; Picado O; Franceschi D; Livingstone AS; Yakoub D
    Am J Surg; 2019 Aug; 218(2):323-328. PubMed ID: 30471808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.
    Shnyder SD; Hayes AJ; Pringle J; Archer CW
    Br J Cancer; 1998 Sep; 78(6):757-9. PubMed ID: 9743295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers.
    Zagami P; Comandone A; Fiore M; Baldi GG; Grignani G; Vincenzi B; Gronchi A; Antonarelli G; Boglione A; Pennacchioli E; Curigliano G; Conforti F; De Pas TM
    Cancer Med; 2023 Aug; 12(16):17047-17055. PubMed ID: 37455549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of claudins and prognostic factors in some gastrointestinal diseases].
    Gyorffy H
    Magy Onkol; 2009 Dec; 53(4):377-83. PubMed ID: 20071310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
    Li XQ; Tu L; Wang M; Ma XL; Yang LX; Shen YY; Zhuang C; Zhao WY; Qiu JF; Zhao G; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):872-879. PubMed ID: 32927512
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.
    Hilal L; Barada K; Mukherji D; Temraz S; Shamseddine A
    Med Oncol; 2016 Feb; 33(2):20. PubMed ID: 26786155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
    Ihle MA; Huss S; Jeske W; Hartmann W; Merkelbach-Bruse S; Schildhaus HU; Büttner R; Sihto H; Sundby Hall K; Eriksson M; Reichardt P; Joensuu H; Wardelmann E
    PLoS One; 2018; 13(2):e0193048. PubMed ID: 29451912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
    Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
    Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors.
    Huang WK; Akçakaya P; Gangaev A; Lee L; Zeljic K; Hajeri P; Berglund E; Ghaderi M; Åhlén J; Bränström R; Larsson C; Lui WO
    Exp Cell Res; 2018 Oct; 371(1):287-296. PubMed ID: 30149002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison.
    Clary BM; DeMatteo RP; Lewis JJ; Leung D; Brennan MF
    Ann Surg Oncol; 2001 May; 8(4):290-9. PubMed ID: 11352301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of primary leiomyosarcoma of the gastrointestinal tract following recognition of gastrointestinal stromal tumours.
    Yamamoto H; Handa M; Tobo T; Setsu N; Fujita K; Oshiro Y; Mihara Y; Yoshikawa Y; Oda Y
    Histopathology; 2013 Aug; 63(2):194-207. PubMed ID: 23763337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor II messenger RNA-binding protein 3 expression in gastrointestinal mesenchymal tumors.
    Yamamoto H; Arakaki K; Morimatsu K; Zaitsu Y; Fujita A; Kohashi K; Hirahashi M; Motoshita J; Oshiro Y; Oda Y
    Hum Pathol; 2014 Mar; 45(3):481-7. PubMed ID: 24411949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein.
    Zheng H; Liu Z; Liu T; Cai Y; Wang Y; Lin S; Chen J; Wang J; Wang Z; Jiang B
    Oncotarget; 2014 Nov; 5(21):10763-77. PubMed ID: 25333257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin.
    Gaumann A; Tews DS; Mentzel T; Petrow PK; Mayer E; Otto M; Kirkpatrick CJ; Kriegsmann J
    Virchows Arch; 2003 Jun; 442(6):529-37. PubMed ID: 12743815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib.
    Théou N; Gil S; Devocelle A; Julié C; Lavergne-Slove A; Beauchet A; Callard P; Farinotti R; Le Cesne A; Lemoine A; Faivre-Bonhomme L; Emile JF
    Clin Cancer Res; 2005 Nov; 11(21):7593-8. PubMed ID: 16278376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.